Dyne Therapeutics, Inc. (DYN) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $214.83M | +249.9% |
| 2024 | $61.40M | -16.8% |
| 2023 | $73.79M | +36.7% |
| 2022 | $53.96M | -6.1% |
| 2021 | $57.47M | +424.0% |
| 2020 | $10.97M | +357.0% |
| 2019 | $2.40M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $214.83M | +249.9% |
| 2024 | $61.40M | -16.8% |
| 2023 | $73.79M | +36.7% |
| 2022 | $53.96M | -6.1% |
| 2021 | $57.47M | +424.0% |
| 2020 | $10.97M | +357.0% |
| 2019 | $2.40M | — |